Summary of Benefits and Coverage

Summary of Benefits and Coverage and Uniform Glossary Required Under the Affordable Care Act

Diabetes-Narrative-11-2019

Summary of Benefits and Coverage

OMB: 1210-0147

Document [pdf]
Download: pdf | pdf
Management of Type 2 Diabetes

(DT - OMB control number: 1545-0047/Expiration Date:
12/31/2019)(DOL - OMB control number: 1210-0147/
Expiration date: 5/31/2022)(HHS - OMB control number:
0938-1146/Expiration date: 10/31/2022)

A 52-year-old man has type 2 diabetes. His diabetes is well controlled with metformin (500 mg) twice
daily and long-acting insulin (Insulin glargine 100 ml/unit injectable solution, 20 units), administered
once daily. He does not have any other complications associated with his diabetes. He is also on
Lisinopril (20 mg) to maintain appropriate blood pressure and kidney function, and aspirin as a
cardiovascular preventive service. He visits his primary care physician four times a year, his podiatrist
once a year, and his ophthalmologist once a year. Twice yearly he receives tests for his hemoglobin A1C.
Once a year he receives blood tests for microalbuminuria, a lipid panel, and a comprehensive metabolic
panel. He purchases medication and supplies as needed, including testing supplies so he can test his
insulin levels. In addition, he receives diabetes self-management education and medical nutrition therapy
education.
He receives an annual influenza vaccine, but has never received a pneumococcal vaccine, so he will
receive one this year and another after he turns 65 years of age. His glucagon kit has expired so he will
purchase a new kit this year.

DISCLAIMER: This narrative and the accompanying benefit scenario illustrate care for a hypothetical
patient receiving treatment for type 2 diabetes. The care, and cost of care, will vary for each patient. No
portion of this narrative or the accompanying benefit scenario should be construed as recommendations
for care, or cost of care, by the United States Government.

PRA Disclosure Statement: According to the Paperwork Reduction Act of 1995, no persons are required
to respond to a collection of information unless it displays a valid OMB control number. The valid OMB
control number for this information collection is 0938-1146 (Expires 10/31/2022). The time required to
complete this information collection is estimated to average [0.08] hours per response, including the time
to review instructions, search existing data resources, gather the data needed, and complete and review the
information collection. If you have comments concerning the accuracy of the time estimate(s) or
suggestions for improving this form, please write to: CMS, 7500 Security Boulevard, Attn: PRA Reports
Clearance Officer, Mail Stop C4-26-05, Baltimore, Maryland 21244-1850.


File Typeapplication/pdf
File TitleDiabetes-Narrative
SubjectSBC Narrative
AuthorAcumen, LLC
File Modified2019-10-30
File Created2019-04-15

© 2024 OMB.report | Privacy Policy